Buel Rodgers

Aavogen, Inc.

$4,616,268

Attributed

$4,728,767

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,728,767 · 5

By mechanism

R44$3,879,616 · 2

R43$849,151 · 3

Top collaborators

Ramzi J Khairallah1 shared

Others in their field

Other Emerging Leaders on “Muscular Atrophy”

Amy Brower · American College Of Medical Genetics$8,744,067
Russell T Hepple · California Pacific Med Ctr Res Institute$6,766,483
Harshini Neelakantan · Ridgeline Therapeutics, Llc$5,471,916
Elizabeth Marjorie Cespedes Feliciano · Columbia University Health Sciences$5,228,035
Patricio Sepulveda · Amplo Biotechnology, Inc.$4,856,116
Helen C Miranda · Case Western Reserve University$3,600,204

Research focus

Muscular AtrophyTherapeutic GenePreventMuscle FunctionClinical TrialsPublic HealthInnovationMuscle FormStriated MusclesGene TherapyRecombinantsAdeno-Associated Viral VectorMuscle ProteinsAttenuatedActivinsSignal TransductionMadh7 GeneGdf8 GeneProtein BiosynthesisOverexpressionGdf11 GeneLigandsTechnologyQuality Of Life